Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery
2007

Identifying Hidden Cancer in Thyroid Patients

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Schott Matthias, Willenberg Holger S, Sagert Cornelia, Nguyen Thi-Bang-Tam, Schinner Sven, Cohnen Mathias, Cupisti Kenko, Eisenberger Claus F, Knoefel Wolfram T, Scherbaum Werner A

Primary Institution: Department of Endocrinology, Diabetes and Rheumatology, Heinrich-Heine-University Duesseldorf, Germany

Hypothesis

Can pentagastrin-stimulated calcitonin sampling improve the detection of small cervical tumors in medullary thyroid carcinoma patients?

Conclusion

The study suggests that using pentagastrin stimulation for calcitonin sampling can help identify tumor-affected regions in patients with medullary thyroid carcinoma after thyroidectomy.

Supporting Evidence

  • An early calcitonin peak after pentagastrin injection correlates with tumor presence.
  • Four out of six patients had small tumors identified post-surgery.
  • Post-surgical calcitonin levels decreased significantly in four patients.

Takeaway

Doctors can use a special test to find tiny tumors in the neck of patients with thyroid cancer, which helps them know where to operate.

Methodology

The study involved pentagastrin-stimulated intravenous calcitonin sampling followed by high-resolution ultrasound in six patients.

Limitations

The method may only be effective for tumors confined to the neck and with slightly elevated calcitonin levels.

Participant Demographics

Six patients with medullary thyroid carcinoma, five with sporadic MTC and one with MEN2a.

Digital Object Identifier (DOI)

10.1111/j.1365-2265.2007.02747.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication